CEO Spotlight: FendX Technologies
This is a paid advertisement on behalf of FendX Technologies Inc. Today, we have FendX Technologies CEO Carolyn Myers with us and we are excited to learn more about her…
FendX Technologies: A Deep Dive
This is a paid message on behalf of FendX Technologies Inc. Although the COVID pandemic created numerous challenges for the global economy, it facilitated the advancement of several industries. From…
Lexaria Biotech: An Undervalued Growth Opportunity
Last month, we highlighted Lexaria Bioscience Corp. (Nasdaq: LEXX) as a biotech company that was trading at a discount and wanted to issue an update after it made several important…
Green Battery Minerals Is An Underappreciated Growth Story
Last month, we published an article of Green Battery Minerals Inc. (TSX-V: GEM) (FSE: BK2P) (WKN: A2QENP) (OTC: GBMIF) as a Canadian junior miner that is flying under the radar…
CEO Spotlight: Green Battery Minerals
Earlier this month, we published an article on Green Battery Minerals Inc. (TSX-V: GEM) (FSE: BK2P) (WKN: A2QENP) (OTC: GBMIF), a Canadian junior miner that is highly focused on mining…
Green Battery Minerals: A Deep Dive
The electric vehicle (EV) revolution represents one of the most attractive current investment themes and we do not expect this to change anytime soon. From an increasing amount of EVs…
Lexaria Bioscience Continues To Execute
Last week, Lexaria Bioscience Corp. (Nasdaq: LEXX) reported two major developments that our readers should be aware of. The more significant announcement was Lexaria awarding a contract for clinical research…
LevelJump Healthcare Is On The Move…This Is Just The Beginning
A few weeks ago, we highlighted LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) as an emerging growth story that is flying under the radar. We hope you followed…
An Undervalued Growth Opportunity in Europe’s Energy Crisis
Microcap European natural gas explorer plans to drill at high-impact sites in Austria and Germany this year. Additionally, they are shooting 3D seismic at another field and applying to double…
Lexaria Awards CRO Contract for Upcoming U.S. Phase 1b Hypertension Study
KELOWNA, BC / ACCESSWIRE / April 24, 2023 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces it has awarded the contract for…
